Thromboxane receptor blockade versus cyclooxigenase inhibition: antiplatelet effects in patients.

Riess, H

Thromboxane receptor blockade versus cyclooxigenase inhibition: antiplatelet effects in patients. [electronic resource] - Thrombosis research Apr 1986 - 235-45 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial

0049-3848

10.1016/0049-3848(86)90299-9 doi


15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
Angioplasty, Balloon
Arteriosclerosis--therapy
Aspirin--therapeutic use
Bleeding Time
Blood Platelets--drug effects
Clinical Trials as Topic
Collagen--pharmacology
Cyclooxygenase Inhibitors
Female
Fibrinolytic Agents--therapeutic use
Humans
Male
Middle Aged
Platelet Aggregation--drug effects
Prostaglandin Endoperoxides, Synthetic--pharmacology
Receptors, Cell Surface--drug effects
Receptors, Prostaglandin--drug effects
Receptors, Thromboxane
Sulfonamides--therapeutic use
Thromboxane B2--blood
Thromboxanes--blood